|
<< Back to Previous Page
Paul K. Gorecki
Research Professor
Paul.Gorecki@esri.ie
Paul Gorecki is Programme Coordinator of the Competition and Regulation Research Area. He joined the ESRI in January 2009.
He gained degrees in economics from Queen Mary College, University of London (BSc), Queen’s University, Canada (MA) and the London School of Economics and Political Science, University of London (PhD), as well as a Postgraduate Diploma in European Community Competition Law (King’s College, University of London)
Paul Gorecki has a longstanding interest in both competition and regulation. As a member of the Irish Competition Authority between 2000 and 2008, he had responsibility for civil enforcement and, subsequently, the merger provisions of the Competition Act 2002. He led on landmark civil cases in respect of the Irish League of Credit Unions, for abuse of a dominant position, and the Beef Industry Development Society, for co-ordinated action to reduce capacity.
Paul Gorecki’s earlier research on the dynamics of the competitive process - market entry and exit of firms, firm growth and decline, productivity of start-ups – not only informs the debate on competition but also industrial policy. This research used a specially created data set that tracked individual firms (and their associated plants) annually over a 10 year period in Canada’s manufacturing sector.
Paul Gorecki managed and conducted research as part of a wide ranging government sponsored project into regulation in Canada, which included: the scope and growth of regulation, the rationale for regulation, and case studies on price and/or entry (taxis, airlines), environmental (SO2 emissions), and common property (fisheries) regulation. The final output was a series of individual authored publications and two reports that built on this research to make policy recommendations to government.
Paul Gorecki’s own research addressed the question of whether a series of policy measures - compulsory drug patent licensing; product selection laws; and the pricing and other reimbursement rules of provincial government drug plans – resulted in lower priced prescription drugs. (The answer is yes). Subsequently he was asked to participate in a number of government inquiries into various aspects of pricing of prescription drugs, while also acting as expert witness for the government in a patent case related to compulsory drug patent licensing. This interest in the pricing of prescription drugs has continued in Ireland.
Paul Gorecki has published widely on competition and regulation.
He was also a Visiting Assistant Professor at the Department Economics and Commerce at Simon Fraser University, Canada and was Director of the Northern Ireland Economic Council between 1992 and 2000.
Download CV and pre-ESRI Publications.
<< Back to Previous Page
|
